Loading…
EFFERVESCENT CALCIUM GLUCONATE is a brand name for Calcium Gluconate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: 1) As an adjunct to conventional therapy in the arrest or slowing down of bone demineralisation in osteoporosis where other effective treatment is contraindicated. 2) In the arrest or slowing down of bone demineralisation in osteoporosis where other effective treatment is contraindicated. 3) Therapeutic…
Verbatim from this product's MHRA label. Tap a section to expand.
Posology The tablets must be dissolved in one third to one half a tumblerful of water. 5mEq/l). Treatment or therapeutic supplementation should aim to restore or maintain this level.
Adults (including elderly):
Osteoporosis: A daily supplement of 800mg (20mmol) calcium or 8-9 tablets may reduce the rate of bone loss, but larger doses have not been shown to be more effective.
Indication:
Daily dosage: Osteoporosis Post-gastrectomy malabsorption 12-20 tablets Osteomalacia and rickets Lactation Pregnancy supplement 1-10 tablets Pregnancy cramps Children: Children require approximately half the adult dosage.
Infants:
A more suitable dosage form should be used for this age group. Method of Administration To be dissolved in water for oral administration.
Other brands of Calcium Gluconate in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
Mild gastrointestinal disturbances have occurred rarely (eg constipation, diarrhoea). Cardiac arrhythmias and bradycardia may also occur. Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important.
It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Calcium salts should be given cautiously to patients with cardiac disease or sarcoidosis. Careful monitoring of blood levels and urinary calcium excretion is necessary, particularly when high dose or parenteral calcium therapy has been used, especially in children.
5mmol)/24 hours) as well as in mild to moderate renal failure, or where there is evidence of stone formation in the urinary tract, adequate checks must be kept on urinary calcium excretion; if necessary the dosage should be reduced or calcium therapy discontinued.
High vitamin D intake should be avoided during calcium therapy, unless especially indicated. Effervescent Calcium Gluconate Tablets BP must be used with care in patients receiving alternative compound vitamin or mineral preparations, which often contain sources of additional calcium.
75mmol/litre (105-110mg/litre) or if urinary calcium excretion exceeds 5mg/kg. 14% of the WHO recommended maximum daily intake for sodium. 8% of the WHO recommended maximum daily intake for sodium. Effervescent Calcium Gluconate Tablets is considered high in sodium.
This should be particularly taken into account for those on a low salt diet.
1. Severe hypercalcaemia and hypercalciuria (eg in hypervitaminosis D, hyperparathyroidism, severe renal failure and renal calculi, osteoporosis due to immobility and decalcifying tumours such as plasmocytoma and skeletal metastases).
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.